The last point of our investigation was aimed to investigate whether AURKA-PLK1-FOXM1 axis participates in the resistance to TK inhibitors of CML LSC. This evidence concerns the gene PLK1 and chronic myelogenous leukemia, BCR-ABL1 positive.